ALLISON REGO: Open Payments
NPI 1417735994 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 43 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $2,362 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $277 |
| ABBVIE INC. | 12 | $225 |
| Gilead Sciences, Inc. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 3 | $108 |
| Lilly USA, LLC | 1 | $101 |
| Ardelyx, Inc. | 5 | $94 |
| Janssen Biotech, Inc. | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| PFIZER INC. | 3 | $61 |
| Novo Nordisk Inc | 3 | $54 |
Products named: REZDIFFRA, Livdelzi, VOQUEZNA, OMVOH, IBSRELA, TREMFYA, RINVOQ, SKYRIZI.
Industry payments across FL — which companies pay providers there.
